ENVA vs GILD · P/E 13, rev $1.80B vs P/E 18, rev $7.80B
Enova International Inc (ENVA) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Enova International Inc (ENVA) is a credit services company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported ENVA revenue for 2026-06-30 was $1.80B. Net income was $196.2M. ENVA currently screens at market cap $3.95B and trailing P/E 12.9.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
ENVA currently screens at market cap $3.95B and trailing P/E 12.9. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the ENVA and GILD stock pages for the full models.
Not investment advice.